Focus Stocks
Perrigo Company to Present at the Leerink Swann 2012 Global Healthcare Conference
Published on Wednesday, 08 February 2012 10:16 Written by TradersHuddle Staff
ALLEGAN, Mich., Feb. 8, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo CFO Judy Brown will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15th, at 2:30 PM (EST) at the Waldorf Astoria in New York.
Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).
Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 25, 2011, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Perrigo
Related Articles
- Perrigo Company To Present At Upcoming Healthcare Conferences
- Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
- Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
- Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
- Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
- Perrigo Company Announces Quarterly Dividend
- Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
- Perrigo Announces the Launch of Guaifenesin Extended-Release 600mg Tablets -- to Compare to Mucinex® 600mg
- Perrigo Announces Australian Approval for Generic Temozolomide
- Perrigo Company to Present at the Barclays Capital Global Healthcare Conference
Related Partner Headlines
- Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream - Benzinga
- Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules - Benzinga
- Perrigo Company (PRGO): Today's Featured Health Care Winner - TheStreet.com
- UPDATE: Stifel Nicolaus Initiates Perrigo Company with Buy, $125 PT; Leading Store Brand Pharma - Benzinga
- UPDATE: Deutsche Bank Lowers Perrigo's PT - Benzinga
- Perrigo Stock Hits New 52-Week High (PRGO) - TheStreet.com
- Perrigo Stock To Go Ex-dividend Tomorrow (PRGO) - TheStreet.com
- Unpeeling the 'Trade-Down' Trade - TheStreet.com
- UPDATE: Perrigo Announces the Launch of Loratadine-D 12 Store Brand Labels - Benzinga
- Collins Stewart Says to Buy Perrigo on Weakness - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com -
Bain Capital Sent 0,000-Plus to Obama and Dems in 2008 - TheStreet.com -
Market Preview: Low-Grade Uncertainty - TheStreet.com -
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com -
Infoblox Posts Blowout Earnings; Shares Rise - TheStreet.com -
Salesforce.com Inc. (CRM): Today's Featured Computer Software & Services Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends -
Law Office of Brodsky & Smith, LLC Announces Investigation of Ariba, Inc. -
Following Its Record 73% Jump FY 2011 Revenue, Privately-Held Milton Security Group Reports Repeat Double-Digit Sales Growth for First Quarter 2012 -
Diamond Value Management strategy and corporate turnaround leverages Rockwell repositioning -
Verizon Singapore Lauded for Its Sustainability Efforts -
Photo Release -- Cars For a Living: The World's First High-Octane Business Podcast









